Refocusing Research on Sexually Transmitted Infections.
refocusing biomedical research
sexually transmitted infections
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
01 10 2020
01 10 2020
Historique:
received:
21
08
2019
accepted:
27
08
2019
pubmed:
10
9
2019
medline:
10
3
2021
entrez:
10
9
2019
Statut:
ppublish
Résumé
This article highlights biomedical research goals for the development of critical tools, including innovative diagnostics, safe and effective vaccines, and new and improved therapeutics, necessary to achieve an end to the global epidemic of sexually transmitted infections. The incidence of sexually transmitted infections (STIs), including gonorrhea, syphilis, chlamydia, and trichomoniasis, is increasing by over 1 million new cases daily and represents a global public health crisis. There is an alarming increase of gonorrhea and syphilis among men who have sex with men and bisexual men, 2 key populations also at high risk for human immunodeficiency virus. A refocused, dedicated, and intensive biomedical research program is needed targeting development of innovative diagnostics, safe and effective vaccines, and new and improved therapeutics. This article highlights biomedical research goals providing critical tools necessary to achieve an end to the global STIs epidemic.
Identifiants
pubmed: 31495889
pii: 5564379
doi: 10.1093/infdis/jiz442
pmc: PMC7529043
doi:
Substances chimiques
Anti-Infective Agents
0
Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1432-1434Informations de copyright
Published by Oxford University Press for the Infectious Diseases Society of America 2019. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Références
Curr Opin Infect Dis. 2017 Feb;30(1):77-86
pubmed: 27922851
Lancet HIV. 2019 Jul;6(7):e415-e416
pubmed: 31178285
Mol Cell Proteomics. 2019 Jan;18(1):127-150
pubmed: 30352803
Bull World Health Organ. 2019 Aug 1;97(8):548-562P
pubmed: 31384073
Lancet. 2017 Sep 30;390(10102):1603-1610
pubmed: 28705462
Sex Transm Infect. 2017 Dec;93(S4):S16-S21
pubmed: 29223959
N Engl J Med. 2018 Nov 8;379(19):1835-1845
pubmed: 30403954
Sex Transm Dis. 2015 Feb;42(2):98-103
pubmed: 25585069
Sex Transm Dis. 2018 Sep;45(9S Suppl 1):S17-S19
pubmed: 29528992
Vaccine. 2015 Aug 26;33(36):4520-4525
pubmed: 26192351
Sex Transm Dis. 2017 Apr;44(4):211-218
pubmed: 28282646
Sex Transm Infect. 2017 Dec;93(S4):S3-S15
pubmed: 28747410
Lancet Infect Dis. 2018 Mar;18(3):308-317
pubmed: 29229440
JAMA. 2019 Mar 5;321(9):844-845
pubmed: 30730529
Sex Transm Infect. 2017 Dec;93(S4):S22-S30
pubmed: 29223960